Relenza Prophylaxis Indication Withdrawn In EU; Pediatric Use Cleared In U.S.

Glaxo Wellcome's influenza medication Relenza for prevention of flu was withdrawn from the EU mutual recognition process so the company could resubmit the application with more data in elderly and high-risk patients, Glaxo said.